T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Kratos Defense & Security Solutions
KTOS
$11.8B
| $1.26M | ﹤0.01% |
54,970
+180
| +0.3% | +$3.4K |
|
1752
First Merchants
FRME
$2.72B
| $1.26M | ﹤0.01% |
33,162
+107
| +0.3% | +$3.92K |
|
1753
Manulife Financial
MFC
$72.9B
| $1.25M | ﹤0.01% |
68,914
+860
| +1% | +$15.3K |
|
1754
Dycom Industries
DY
$12.3B
| $1.25M | ﹤0.01% |
21,295
+94
| +0.4% | +$4.81K |
|
|
PDM
1755
Piedmont Realty Trust
PDM
$1.2B
| $1.25M | ﹤0.01% |
62,887
-5,920
| -9% | -$122K |
|
|
DOC
1756
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.25M | ﹤0.01% |
71,763
+1,005
| +1% | +$18.3K |
|
|
MZTI
1757
The Marzetti Company
MZTI
$3.22B
| $1.25M | ﹤0.01% |
8,418
+47
| +0.6% | +$7.04K |
|
1758
Diamondrock Hospitality Co
DRH
$2.51B
| $1.25M | ﹤0.01% |
120,729
+351
| +0.3% | +$3.7K |
|
1759
Hancock Whitney
HWC
$6.37B
| $1.25M | ﹤0.01% |
31,164
+214
| +0.7% | +$8.81K |
|
1760
S&T Bancorp
STBA
$1.82B
| $1.24M | ﹤0.01% |
33,136
+71
| +0.2% | +$2.75K |
|
1761
Navient
NAVI
$867M
| $1.24M | ﹤0.01% |
90,843
-346
| -0.4% | -$4.51K |
|
|
TWO
1762
Two Harbors Investment
TWO
$1.26B
| $1.23M | ﹤0.01% |
24,308
+1,307
| +6% | +$68.6K |
|
1763
Coca-Cola Europacific Partners
CCEP
$47.5B
| $1.23M | ﹤0.01% |
21,781
+570
| +3% | +$31.1K |
|
1764
Bank OZK
OZK
$5.7B
| $1.23M | ﹤0.01% |
40,922
+118
| +0.3% | +$3.66K |
|
1765
InterDigital
IDCC
$8.88B
| $1.23M | ﹤0.01% |
19,053
+156
| +0.8% | +$10.4K |
|
1766
Evercore
EVR
$12B
| $1.22M | ﹤0.01% |
13,778
+29
| +0.2% | +$2.58K |
|
1767
First Financial Bancorp
FFBC
$3.6B
| $1.21M | ﹤0.01% |
49,742
+301
| +0.6% | +$7.23K |
|
|
MCHB
1768
Mechanics Bancorp
MCHB
$3.79B
| $1.2M | ﹤0.01% |
40,607
+102
| +0.3% | +$2.93K |
|
1769
Stock Yards Bancorp
SYBT
$2.64B
| $1.2M | ﹤0.01% |
33,272
-3,660
| -10% | -$127K |
|
1770
CVR Energy
CVI
$3.58B
| $1.2M | ﹤0.01% |
23,957
+259
| +1% | +$11.6K |
|
1771
OraSure Technologies
OSUR
$277M
| $1.2M | ﹤0.01% |
129,039
+10,651
| +9% | +$98K |
|
1772
CONMED
CNMD
$1.49B
| $1.2M | ﹤0.01% |
13,961
+101
| +0.7% | +$8.3K |
|
1773
Neogen
NEOG
$2.59B
| $1.19M | ﹤0.01% |
38,350
+280
| +0.7% | +$8.25K |
|
1774
City Holding Co
CHCO
$2.08B
| $1.19M | ﹤0.01% |
15,559
+42
| +0.3% | +$3.23K |
|
1775
Yelp
YELP
$1.32B
| $1.19M | ﹤0.01% |
34,684
+157
| +0.5% | +$5.43K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.